The global aplastic anemia market is set for steady growth over the coming decade. Valued at US$ 6.7 billion in 2023, the market is expected to expand at a CAGR of 4.3% from 2024 to 2034, reaching US$ 10.8 billion by the end of the forecast period. Rising incidence of aplastic anemia, increasing clinical trials, and ongoing advancements in therapeutics are fueling the market’s expansion,...